McKesson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. 

CEO
Brian Scott Tyler
CEOBrian Scott Tyler
Employees
43,000
Employees43,000
Headquarters
Irving, Texas
HeadquartersIrving, Texas
Founded
1833
Founded1833
Employees
43,000
Employees43,000

MCK Key Statistics

Market cap
127.79B
Market cap127.79B
Price-Earnings ratio
28.62
Price-Earnings ratio28.62
Dividend yield
0.32%
Dividend yield0.32%
Average volume
718.61K
Average volume718.61K
High today
$1,121.50
High today$1,121.50
Low today
$1,065.00
Low today$1,065.00
Open price
$1,085.84
Open price$1,085.84
Volume
704.32K
Volume704.32K
52 Week high
$1,121.50
52 Week high$1,121.50
52 Week low
$723.68
52 Week low$723.68

Stock Snapshot

The current McKesson(MCK) stock price is $1,096.04, with a market capitalization of 127.79B. The stock trades at a price-to-earnings (P/E) ratio of 28.62 and offers a dividend yield of 0.32%.

As of 2026-11-05, McKesson(MCK) stock has fluctuated between $1,065.00 and $1,121.50. The current price stands at $1,096.04, placing the stock +2.9% above today's low and -2.3% off the high.

The McKesson(MCK)'s current trading volume is 704.32K, compared to an average daily volume of 718.61K.

During the past year, McKesson(MCK) stock moved between $723.68 at its lowest and $1,121.50 at its peak.

During the past year, McKesson(MCK) stock moved between $723.68 at its lowest and $1,121.50 at its peak.

MCK News

Simply Wall St 8h
CVS Health Breakup Puts McKesson Stock And Pharmacy Rivals In Focus

When a giant like CVS Health decides to split its pharmacy, insurance and benefits engine into two separate companies, it sends a clear signal that the retail d...

CVS Health Breakup Puts McKesson Stock And Pharmacy Rivals In Focus
Barchart 19h
McKesson’s Q3 CY2026 adjusted EPS top estimates - Barchart.com

...

McKesson’s Q3 CY2026 adjusted EPS top estimates - Barchart.com
Zacks 20h
McKesson Beats Q2 Earnings and Revenue Estimates

McKesson (MCK Quick QuoteMCK - Free Report) came out with quarterly earnings of $11.68 per share, beating the Zacks Consensus Estimate of $10.69 per share...

McKesson Beats Q2 Earnings and Revenue Estimates

Analyst ratings

75%

of 20 ratings
Buy
75%
Hold
25%
Sell
0%

More MCK News

Simply Wall St 2d
McKesson Earnings Beat Raises The Question Of Whether The Stock Is Fully Valued

McKesson (MCK) is back in focus after strong third quarter results, with adjusted earnings per share up 20%, GLP-1 distribution reaching $15b, higher full year...

McKesson Earnings Beat Raises The Question Of Whether The Stock Is Fully Valued
Simply Wall St 5d
Strong Earnings Outlook Could Be A Game Changer For McKesson Stock

McKesson's board has affirmed a regular dividend of US$0.94 per share, payable on January 4, 2027, to shareholders of record on December 1, 2026. This signals o...

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.